News | May 05, 2023
Merck plans bioprocessing center in South Korea
The planned bioprocessing facility would support commercial manufacturing for biotech and pharmaceutical customers across Asia-Pacific.
The planned bioprocessing facility would support commercial manufacturing for biotech and pharmaceutical customers across Asia-Pacific.
Pheezee is designed to assess musculoskeletal and neuromuscular health.
The partnership will commercialize four nasal sprays with a combined Global IQVIA market size in excess of $400m
He has over two decades of leadership experience as an innovative strategic planner in finance diligence
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
The consolidated EBITDA stood at Rs. 89.3 crore in FY23 as compared to Rs. 164.5 crore in the same period last year
It will help in bringing a significant benefit in compliance of ARV medication in the paediatric HIV treatment
Specialty Chemicals grew 38% YoY for FY23
This approval reflects Biocon Biologics' compliance with the highest international regulatory standards
Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23
Subscribe To Our Newsletter & Stay Updated
